Y Lin1, L-X Wang2, L-X Qiu3, Q Huang3, Q Shu3, H-X Lin4, X Meng5, X-L Zeng6, L-X Xiao7, T S Bam8, C-Y Chiang9. 1. International Union Against Tuberculosis and Lung Disease (The Union), Beijing, China. 2. China Center of Tuberculosis Control and Prevention, Beijing, China. 3. Jiangxi Provincial Institute of Tuberculosis Control and Prevention, Nanchang, China. 4. Tobacco Control Office, China Center for Disease Control and Prevention, Beijing, China. 5. Ganzhou Prefecture Centers for Disease Control and Prevention, Ganzhou, Jiangxi Province, China. 6. Ningdu County Tuberculosis Dispensary, Ningdu, Jiangxi Province, China. 7. Xingguo County Tuberculosis Dispensary, Xingguo, Jiangxi Province, China. 8. The Union, Singapore. 9. The Union, Paris, France ; Division of Pulmonary Medicine, Department of Internal Medicine, Wan Fang Hospital, Taipei Medical University, Taipei, Taiwan.
Abstract
OBJECTIVE: To assess the integration of a smoking cessation intervention into routine tuberculosis (TB) services. METHOD: Consecutive TB patients registered from 1 March to 31 August 2010 were enrolled in an intervention for self-reported smoking to promote tobacco cessation during treatment for TB. Information on the harmful health effects of tobacco smoke and smoking and TB were provided to TB patients who self-reported as current smokers. Smoking status was reassessed at every follow-up visit during anti-tuberculosis treatment with reinforced health messages and advice to quit. RESULTS: Of 800 TB patients enrolled, 572 (71.5%) were male and 244 (30.5%) were current smokers. Females were more likely to be non-smokers (100% vs. 35.8%, P < 0.001). Of the 244 current smokers, 144 (59.0%) started smoking at <20 years, 197 (80.7%) consumed ⩾20 cigarettes per day, 211 (86.5%) had perceived smoking dependence and 199 (81.6%) had made no attempt to quit before the diagnosis of TB. Of the 244 current smokers, 234 (95.9%) were willing to quit, and 156 (66.7%) reported abstinence at month 6. Challenges to implementing smoking cessation intervention were identified. CONCLUSION: The majority of current smokers among TB patients were willing to quit and remained abstinent at the end of anti-tuberculosis treatment. This intervention should be scaled up nationwide.
OBJECTIVE: To assess the integration of a smoking cessation intervention into routine tuberculosis (TB) services. METHOD: Consecutive TB patients registered from 1 March to 31 August 2010 were enrolled in an intervention for self-reported smoking to promote tobacco cessation during treatment for TB. Information on the harmful health effects of tobacco smoke and smoking and TB were provided to TB patients who self-reported as current smokers. Smoking status was reassessed at every follow-up visit during anti-tuberculosis treatment with reinforced health messages and advice to quit. RESULTS: Of 800 TB patients enrolled, 572 (71.5%) were male and 244 (30.5%) were current smokers. Females were more likely to be non-smokers (100% vs. 35.8%, P < 0.001). Of the 244 current smokers, 144 (59.0%) started smoking at <20 years, 197 (80.7%) consumed ⩾20 cigarettes per day, 211 (86.5%) had perceived smoking dependence and 199 (81.6%) had made no attempt to quit before the diagnosis of TB. Of the 244 current smokers, 234 (95.9%) were willing to quit, and 156 (66.7%) reported abstinence at month 6. Challenges to implementing smoking cessation intervention were identified. CONCLUSION: The majority of current smokers among TB patients were willing to quit and remained abstinent at the end of anti-tuberculosis treatment. This intervention should be scaled up nationwide.
Authors: S den Boon; S W P van Lill; M W Borgdorff; S Verver; E D Bateman; C J Lombard; D A Enarson; N Beyers Journal: Thorax Date: 2005-07 Impact factor: 9.139
Authors: B N Siddiquea; M A Islam; T S Bam; S Satyanarayana; D A Enarson; A J Reid; Md A Husain; S M Ahmed; S Ferdous; N Ishikawa Journal: Public Health Action Date: 2013-09-21
Authors: C-C Huang; E Tchetgen Tchetgen; M C Becerra; T Cohen; J Galea; R Calderon; R Yataco; C Contreras; Z-B Zhang; L Lecca; M Murray Journal: Int J Tuberc Lung Dis Date: 2014-11 Impact factor: 2.373
Authors: S S Shin; D Xiao; M Cao; C Wang; Q Li; W-X Chai; R P Lindsay; P Usita; T E Novotny Journal: Int J Tuberc Lung Dis Date: 2012-01 Impact factor: 2.373
Authors: George W Reed; Hongjo Choi; So Young Lee; Myungsun Lee; Youngran Kim; Hyemi Park; Jongseok Lee; Xin Zhan; Hyeungseok Kang; SooHee Hwang; Matthew Carroll; Ying Cai; Sang-Nae Cho; Clifton E Barry; Laura E Via; Hardy Kornfeld Journal: PLoS One Date: 2013-02-28 Impact factor: 3.240
Authors: M J Magee; L Darchia; M Kipiani; T Chakhaia; R R Kempker; N Tukvadze; C J Berg; H M Blumberg Journal: Int J Tuberc Lung Dis Date: 2017-06-29 Impact factor: 2.373
Authors: H A Gupte; R Zachariah; K D Sagili; V Thawal; L Chaudhuri; H Verma; A Dongre; A Malekar; N A Rigotti Journal: Public Health Action Date: 2018-06-21
Authors: A Jiamsakul; M-P Lee; K V Nguyen; T P Merati; D D Cuong; R Ditangco; E Yunihastuti; S Ponnampalavanar; F Zhang; S Kiertiburanakul; A Avihingasanon; O T Ng; B L H Sim; W-W Wong; J Ross; M Law Journal: Int J Tuberc Lung Dis Date: 2018-02-01 Impact factor: 2.373
Authors: Genet A Amere; Pratibha Nayak; Argita D Salindri; K M V Narayan; Matthew J Magee Journal: Am J Epidemiol Date: 2018-09-01 Impact factor: 4.897
Authors: O C P Van Schayck; S Williams; V Barchilon; N Baxter; M Jawad; P A Katsaounou; B J Kirenga; C Panaitescu; I G Tsiligianni; N Zwar; A Ostrem Journal: NPJ Prim Care Respir Med Date: 2017-06-09 Impact factor: 2.871